Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Nov 15;307(10):R1181-97.
doi: 10.1152/ajpregu.00208.2014. Epub 2014 Sep 17.

Therapeutic potential of intermittent hypoxia: a matter of dose

Affiliations
Review

Therapeutic potential of intermittent hypoxia: a matter of dose

Angela Navarrete-Opazo et al. Am J Physiol Regul Integr Comp Physiol. .

Abstract

Intermittent hypoxia (IH) has been the subject of considerable research in recent years, and triggers a bewildering array of both detrimental and beneficial effects in multiple physiological systems. Here, we review the extensive literature concerning IH and its impact on the respiratory, cardiovascular, immune, metabolic, bone, and nervous systems. One major goal is to define relevant IH characteristics leading to safe, protective, and/or therapeutic effects vs. pathogenesis. To understand the impact of IH, it is essential to define critical characteristics of the IH protocol under investigation, including potentially the severity of hypoxia within episodes, the duration of hypoxic episodes, the number of hypoxic episodes per day, the pattern of presentation across time (e.g., within vs. consecutive vs. alternating days), and the cumulative time of exposure. Not surprisingly, severe/chronic IH protocols tend to be pathogenic, whereas any beneficial effects are more likely to arise from modest/acute IH exposures. Features of the IH protocol most highly associated with beneficial vs. pathogenic outcomes include the level of hypoxemia within episodes and the number of episodes per day. Modest hypoxia (9-16% inspired O2) and low cycle numbers (3-15 episodes per day) most often lead to beneficial effects without pathology, whereas severe hypoxia (2-8% inspired O2) and more episodes per day (48-2,400 episodes/day) elicit progressively greater pathology. Accumulating evidence suggests that "low dose" IH (modest hypoxia, few episodes) may be a simple, safe, and effective treatment with considerable therapeutic potential for multiple clinical disorders.

Keywords: dose; intermittent hypoxia; pathogenic; review; therapeutic.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Schematic summarizing factors most influential in determining the balance of beneficial vs. pathogenic intermittent hypoxia (IH) effects. IH protocols consisting of severe hypoxia (2–8% inspired O2) and between 48–2,400 cycles/day are prone to pathology; citations demonstrating pathogenic effects of IH are listed in the upper left quadrant (i.e., high cycle numbers per day with relatively severe hypoxemia within episodes, as indicated by orange/red shading). In contrast, IH protocols consisting of moderate IH (>9% inspired O2; <15 cycles/day) appear to elicit beneficial (potentially “therapeutic”) effects with minimal pathology; citations demonstrating beneficial effects of IH are listed in the lower right quadrant (indicated by blue shading). There is unlikely to be a clear division between protocols giving rise to pathogenic/beneficial effects since there is most likely a gradual transition (39); further, details of this transition may differ in detail among physiological systems. Representative literature concerning the range of IH protocols investigated are summarized in Figs. 2 (pathogenic) and 3 (beneficial).
Fig. 2.
Fig. 2.
Selected IH protocols reported to elicit pathology. Each protocol depicts the effective IH “dose,” including the severity of hypoxia during each episode (inspired O2), the duration of hypoxic episodes (6 s to 12 h), the number of cycles per day (c/day), and the total time of exposure. Severe protocols (2–8% inspired O2, 48–2,400 c/day) have been shown to elicit detrimental effects in multiple physiological systems (see orange-to-red shading in Fig. 1).
Fig. 3.
Fig. 3.
Selected IH protocols reported to elicit beneficial (potentially) therapeutic effects. Each protocol depicts the effective IH “dose,” including the severity of hypoxia during each episode (inspired O2), the duration of hypoxic episodes (6 s to 12 h), the number of cycles per day (c/day), and the total time of exposure. Moderate IH protocols consisting of 9–16% O2 and up to 15 cycles per day elicit beneficial effects in multiple physiological systems (blue shading in Fig. 1).

Similar articles

Cited by

References

    1. Aboubakr SE, Taylor A, Ford R, Siddiqi S, Badr MS. Long-term facilitation in obstructive sleep apnea patients during NREM sleep. J Appl Physiol (1985) 91: 2751–2757, 2001. - PubMed
    1. Abraham WC, Bear MF. Metaplasticity: the plasticity of synaptic plasticity. Trends Neurosci 19: 126–130, 1996. - PubMed
    1. Airan RD, Meltzer LA, Roy M, Gong Y, Chen H, Deisseroth K. High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 317: 819–823, 2007. - PubMed
    1. Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AI. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 32: 447–470, 2009. - PMC - PubMed
    1. Arter JL, Chi DSMG, Fitzgerald SM, Guha B, Krishnaswamy G. Obstructive sleep apnea, inflammation, and cardiopulmonary disease. Front Biosci 9: 2892–2900, 2004. - PubMed

Publication types

LinkOut - more resources